Feedback / Questions
tilavonemab (ABBV-8E12) - AbbVie
http://www.ncbi.nlm.nih.gov/pubmed/41449708
Jürgen Götz
Dec 26, 2025
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next